Scaffold for corneal reconstruction using 3D printing and bio-printing

ACELLMED Sp. z o.o. and the Silesian Medical Technology Park Kardio-Med Silesia have estabilished cooperation for the implementation of a project co-financed by the European Regional Developmet Found for the Regional Operational Programme of the Silesia for 204-2020 from Priority Axis I. Modern Economy Measure 1.2 Research, Development and Innovation in Enterprices.

The project is called: „Scaffold for corneal reconstruction using 3D printing and bio-printing”
The aim of the project: development of R&D activity and competitiveness through the implementaion of R&D work, which will result in innovative product in the form of scaffold with embedded stem cells, based on the technology of bio-printing and 3D printing for use in corneal reconstruction. The aim will be achieved in February 2023.
The main scientific aim will be preparation of material composition and technoloy of scaffold as well as the isolation, multiplication and colonization of this scaffold with stem cells from the patient. Acellmed and Silesian Medical Technology Park Kardio-Med Silesia aim to develop a drug that could be used in the procedure of regenerative medicine.

Project assumptions:

  • To obtain a stabel, robust scaffold with acceptable transluency in the surgical procedure, comparable to a comerciallly available product
  • To obtain the ability to source and culture corneal stromal cells and their basic characterization
  • Obtain a sterile and biocompatible scaffold that tested in cell contact or in-vivo
  • To develop a corneal cel model that takes into account the presence of the scaffold material
  • To obtain an alternative method of scaffold production based on atomated and reproducible 3D printing bioprinting)
  • Achieve the ability to uniformly distribute cells on the surface od the scffoldusing 3D printing
  • Demonstrate normal corneal cel growth using at least one of the fabricated scaffolds in vitro
  • Positive evaluation of cel scaffolds for use in surgical procedure
  • Demonstration of the effectiveness of a surgical procedure for corneal repair using the developed prototype

Project implementation period: 1.03.2021 – 28.02.2023

Project value:

  • Eligible expenditure: 4 067 164,81 zł
  • Requested funding: 3 457 090,07 zł


    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    I consent to processing of my personal data contained in the above contact form by Acellmed Ltd. with the registered seat in Zabrze, St. M. Curie-Skłodowskiej 10C, 41-800 Zabrze, to contact in connection with the application sent via the contact form. The consent may be withdrawn at any time without affecting the lawfulness of personal data processing, which was made on the basis of the consent granted before its withdrawal.

    The controller of the personal data, i.e. the entity deciding on the purposes and methods of their processing, is Acellmed Ltd. with the registered seat in Zabrze (41-800), St. Marii Curie - Skłodowskiej 10c, hereinafter referred to as "Acellmed". The contact details of the data protection officer are:

    Privacy policy - more


    St. M. Skłodowskiej-Curie 10c
    41-800 Zabrze, Poland